Lonza
Lonza makes change at the top
April 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, funk
Swiss pharma supplier firm Lonza has confirmed a leadership change as its chief operating officer (COO) leaves. Marc Funk has …
Lonza hires ex-journalist as comms head
March 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, ward
Pharma and biotech supply firm Lonza has appointed Constance Ward to head-up its external communications. She joins Lonza from her …
Lonza wields axe at US facility
August 28, 2013Manufacturing and Production Lonza, cuts
Swiss contract manufacturer Lonza has said it will start cutting staffing levels at its US facility in Hopkinton, Massachusetts, next …
Teva and Lonza abandon biosimilars joint venture
July 26, 2013Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars
Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …
Lonza says 2012 growth was solid, but more restructuring due
January 29, 2013Manufacturing and Production Arch, CMO, Lonza
Swiss contract manufacturing organisation (CMO) and ingredients supplier Lonza posted a 46% increase in revenues to 3.93 billion francs last …
Lonza earmarks $15m for ADC plant expansion
January 14, 2013Manufacturing and Production ADC, API, Lonza, Novasep
Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …
Pharma manufacturing news in brief
December 21, 2012Manufacturing and Production Amarin, BASF, Bioden Idec, Eisai, Lonza, Patheon, Sartorious Stedim Biotech, banner pharmacaps
BASF extends offer for ProNova, Patheon closes Banner Pharmacaps deal, plus updates from Amarin, Biogen Idec/Eisai and Lonza.
Lonza wins contract to make gene therapy for heart failure
October 2, 2012Manufacturing and Production Celladon, Lonza, Mydicar
Lonza has been awarded a contract by US firm Celladon for the manufacture of Mydicar, a gene therapy-based drug candidate …
Pharma manufacturing news in brief
October 2, 2012Manufacturing and Production BIA Seperations, Hovione, Lonza, Merck Millipore
Hovione invests in particle design, Lonza signs deal for ADC production plus bioprocess news from BIA Separations and Merck Millipore.
Pharma manufacturing news in brief
June 19, 2012Manufacturing and Production BioWa, Cytovance Biologics, DHL, Dalton Pharma Services, Lonza, Particle Sciences, Recipharm
DHL opens up a facility in Mumbai, Recipharm invests in French filling plant, plus updates from Dalton Pharma Services, Particle …
New COO for Lonza Life Science Ingredients
June 8, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Beat In-Albon, COO, Lonza
Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector. In-Albon, 60, becomes a member …
Gene therapy specialist and Lonza forge production pact
May 22, 2012Manufacturing and Production Avalanche, Lonza, Phil Taylor
Avalanche Biotechnologies, a US company developing gene therapies for ocular diseases, has signed a manufacturing collaboration with Lonza of Switzerland. …
Lonza names Ridinger as new chief executive
April 5, 2012Manufacturing and Production Cognis, Lonza, Ridinger
Swiss contract manufacturer and ingredients supplier Lonza has appointed Richard Ridinger as its new chief executive, replacing Stefan Borgas who …
Lonza forges joint venture with South Africa for HIV drugs
February 13, 2012Manufacturing and Production HIV, Lonza, South Africa
Swiss contract manufacturer Lonza has signed a joint venture agreement with the government of South Africa that could significantly reduce …
Lonza to make Elan’s Alzheimer’s candidate
December 7, 2011Manufacturing and Production Abbott, Elan, Lonza
Elan has awarded a manufacturing contract to Lonza to supply the active pharmaceutical ingredient (API) for its small-molecule candidate Alzheimer’s …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
